Teratogenicity of the class III antiarrhythmic drug almokalant. Role of hypoxia and reactive oxygen species.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Reproductive Toxicology

• Publication date

  1999-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0890-6238(98)00066-5PMID 10213516
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Developmental toxicity of the class III antiarrhythmic agent almokalant in mice. Adverse effects mediated via induction of embryonic heart rhythm abnormalities.

  2011cited by this paper
• Embryotoxic effects of L-691,121, a class III antiarrhythmic agent, in rats

  2009cited by this paper
• Pharmacologically induced embryonic dysrhythmia and episodes of hypoxia followed by reoxygenation: a common teratogenic mechanism for antiepileptic drugs?

  1998cited by this paper
• Cardiovascular Active Drugs

  1997cited by this paper
• Cardiovascular alterations in rat fetuses exposed to calcium channel blockers.

  1997cited by this paper
• Drug Toxicity in Embryonic Development I

  1997cited by this paper
• Inhibition of delayed rectifier K+ channels by phenytoin in rat neuroblastoma cells

  1997cited by this paper
• Initiation of phenytoin teratogenesis: pharmacologically induced embryonic bradycardia and arrhythmia resulting in hypoxia and possible free radical damage at reoxygenation.

  1997cited by this paper
• Suppressive effects of Bay K 8644 on toxicity of calcium channel blockers in cultured rat embryos.

  1996cited by this paper
• Teratogenic potential of almokalant, dofetilide, and d-sotalol: drugs with potassium channel blocking activity.

  1996cited by this paper
• Developmental changes in ionic channel activity in the embryonic murine heart.

  1996cited by this paper
• Developmental toxicity of ibutilide fumarate in rats after oral administration.

  1996cited by this paper
• Effects of Calcium Channel Blockers on Cultured Rat Embryos

  1996cited by this paper
• Reactive oxygen species in developmental toxicity: review and hypothesis.

  1996cited by this paper
• Studies of mitochondria in oxidative embryotoxicity.

  1995cited by this paper
• Induction of rhythm abnormalities in the fetal rat heart. A tentative mechanism for the embryotoxic effect of the class III antiarrhythmic agent almokalant.

  1994cited by this paper
• Beneficial effects of extracellular glutathione against endotoxin-induced liver injury during ischemia and reperfusion.

  1994cited by this paper
• Role of oxygen free radicals in cocaine-induced vascular disruption in mice.

  1994cited by this paper
• Effects of the class III antiarrhythmic, dofetilide (UK-68,798) on the heart rate of midgestation rat embryos, in vitro.

  1994cited by this paper
• Use-dependent block and use-dependent unblock of the delayed rectifier K+ current by almokalant in rabbit ventricular myocytes.

  1993cited by this paper
• Free radicals in disease processes: a compilation of cause and consequence.

  1993cited by this paper
• Human disease, free radicals, and the oxidant/antioxidant balance.

  1993cited by this paper
• Histopathological and hemodynamic studies supporting hypoxia and vascular disruption as explanation to phenytoin teratogenicity.

  1992cited by this paper
• Parental epilepsy, anticonvulsant drugs, and reproductive outcome: epidemiologic and experimental findings spanning three decades; 1: Animal studies.

  1991cited by this paper
• Parental epilepsy, anticonvulsant drugs, and reproductive outcome: epidemiologic and experimental findings spanning three decades; 2: Human studies.

  1991cited by this paper
• Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds.

  1990cited by this paper
• Oxidative influence on development and differentiation: an overview of a free radical theory of development.

  1989cited by this paper
• Modulation of phenytoin teratogenicity and embryonic covalent binding by acetylsalicylic acid, caffeic acid, and alpha-phenyl-N-t-butylnitrone: implications for bioactivation by prostaglandin synthetase.

  1989cited by this paper
• Cardiac Morphogenesis—Recent Research Advances

  1987cited by this paper
• Teratogen update: fetal hydantoin effects.

  1986cited by this paper
• The role of dysrhythmic heart function during cardiovascular teratogenesis in epinephrine-treated chick embryos.

  1984cited by this paper
• Intracellular cysteine delivery system that protects against toxicity by promoting glutathione synthesis.

  1982cited by this paper
• Hyperoxia and hypoxia in pregnancy: simple experimental manipulation alters the incidence of cleft lip and palate in CL/Fr mice.

  1981cited by this paper
• Cardiovascular alterations in rabbit embryos in situ after a teratogenic dose of hydroxyurea: an in vivo microscopic study.

  1980cited by this paper
• Role of decreased cardiac output in isoproterenol-induced cardiovascular teratogenesis in chick embryos.

  1980cited by this paper
• DPH-induced macrocytosis in the 14-day rat foetus

  1979cited by this paper
• Abnormal Organogenesis of Facial Structures

  1977cited by this paper
• Fetal pathology in rats following uterine-vessel clamping on day 14 of gestation.

  1974cited by this paper
• A rapid method for detecting malformations in rat fetuses

  1969cited by this paper
• Hemodynamic factors in the development of the chick embryo heart

  1965cited by this paper

• Review: Hormone Pregnancy Tests Were Teratogenic by the Same Failed Abortion and Hypoxia‐Related Mechanism as Misoprostol

  2025cites this paper
• Toxic effects of 70% ethanol extract of Moringa stenopetala leaf (Baker f.) Cufod. (Moringaceae) on fetus and placenta of pregnant Wistar rats

  2023cites this paper
• Teratogenicity and Reactive Oxygen Species after transient embryonic hypoxia: Experimental and clinical evidence with focus on drugs causing failed abortion in humans.

  2023influential citation
• Adverse paediatric outcomes of macrolide antibiotics treatment in pregnancy

  2020cites this paper
• The effect of anti-emetic drugs on rat embryonic heart activity.

  2019cites this paper
• Long‐term programming effects on blood pressure following gestational exposure to the I Kr blocker Dofetilide

  2018cites this paper
• Experimental approaches to evaluate mechanisms of developmental toxicity

  2016cites this paper
• KMT2D regulates specific programs in heart development via histone H3 lysine 4 di-methylation

  2016cites this paper
• Uloga obojenoga doplera u dijagnostici fetalnih nakaznosti

  2015cites this paper
• Protective effect of maternal vitamin E supplementation on phenytoin-induced teratogenicity in rat pups

  2015cites this paper
• Effects of macrolide antibiotics on rat embryonic heart function in vitro.

  2014cites this paper
• Teratogenic mechanisms associated with prenatal medication exposure.

  2014cites this paper
• Test Methods for Assessing Female Reproductive and Developmental Toxicology

  2014cites this paper
• Therapeutic drugs that slow the heart rate of early rat embryos. Is there a risk for the human?

  2014cites this paper
• Epidemiology of major congenital malformations with specific focus on teratogens.

  2013cites this paper
• The effect on rat embryonic heart rate of Na+, K+, and Ca2+ channel blockers, and the human teratogen phenytoin, changes with gestational age.

  2013cites this paper
• Assessment of Drug-Induced Cardiotoxicity during Rat Embryo Development

  2013cites this paper
• Exploration of human, rat, and rabbit embryonic cardiomyocytes suggests K-channel block as a common teratogenic mechanism.

  2013cites this paper
• The teratogenic effect of dofetilide during rat limb development and association with drug-induced bradycardia and hypoxia in the embryo.

  2013cites this paper
• Atenção farmacêutica em gestante

  2013cites this paper
• Comparative effects of sodium channel blockers in short term rat whole embryo culture.

  2013cites this paper
• Structure–Activity Relationships, Ligand Efficiency, and Lipophilic Efficiency Profiles of Benzophenone-Type Inhibitors of the Multidrug Transporter P-Glycoprotein

  2012cites this paper
• Developmental toxicity of the class III antiarrhythmic agent almokalant in mice. Adverse effects mediated via induction of embryonic heart rhythm abnormalities.

  2011cites this paper
• Pharmacogenetics of drug-induced birth defects: what is known so far?

  2011cites this paper
• ILSI/HESI maternal toxicity workshop summary: maternal toxicity and its impact on study design and data interpretation.

  2011cites this paper
• Combined ligand- and structure-based studies on inhibitors of P-glycoprotein

  2011cites this paper
• ROLE OF THE HERG- CHANNEL IN ARRHYTHMIA AND TERATOGENICITY. STUDIES IN ANIMAL MODELS AND THE HUMAN EMBRYONIC HEART

  2010influential citation
• Teratogenic mechanisms of medical drugs.

  2010cites this paper
• University of Groningen Teratogenic mechanisms of medical drugs

  2010influential citation
• Homozygous Missense N629D hERG (KCNH2) Potassium Channel Mutation Causes Developmental Defects in the Right Ventricle and Its Outflow Tract and Embryonic Lethality

  2008cites this paper
• Embryonic cardiac arrhythmia and generation of reactive oxygen species: common teratogenic mechanism for IKr blocking drugs.

  2007cites this paper
• Increased susceptibility to phenytoin teratogenicity: excessive generation of reactive oxygen species or impaired antioxidant defense?

  2006cites this paper
• The relationship between cleft lip, maxillary hypoplasia, hypoxia and phenytoin.

  2006cites this paper
• Maternal antioxidant supplementation does not reduce the incidence of phenytoin-induced cleft lip and related malformations in rats.

  2005cites this paper
• Teratogenicity by the hERG potassium channel blocking drug almokalant: use of hypoxia marker gives evidence for a hypoxia-related mechanism mediated via embryonic arrhythmia.

  2003cites this paper
• Embryonic Arrhythmia by Inhibition of HERG Channels: A Common Hypoxia‐related Teratogenic Mechanism for Antiepileptic Drugs?

  2002cites this paper
• Teratogenicity of the I(Kr)-blocker cisapride: relation to embryonic cardiac arrhythmia.

  2002cites this paper
• Common Mechanism for Teratogenicity of Antiepileptic Drugs: Drug-Induced Embryonic Arrhythmia and Hypoxia-Reoxygenation Damage

  2001cites this paper
• Class III antiarrhythmics and phenytoin: teratogenicity due to embryonic cardiac dysrhythmia and reoxygenation damage.

  2001cites this paper
• Stage-specific skeletal and visceral defects of the I(Kr)-blocker almokalant: further evidence for teratogenicity via a hypoxia-related mechanism.

  2001cites this paper
• Developmental toxicity in the pregnant rabbit by the class III antiarrhythmic drug sotalol.

  2001cites this paper
• Phenytoin-induced cleft palate: evidence for embryonic cardiac bradyarrhythmia due to inhibition of delayed rectifier K+ channels resulting in hypoxia-reoxygenation damage.

  2001cites this paper
• Pharmacokinetic data support pharmacologically induced embryonic dysrhythmia as explanation to Fetal Hydantoin Syndrome in rats.

  2000cites this paper
• Pharmacologic Properties of Phenyl N-tert-Butylnitrone

  1999cites this paper